Functionally Complete Revascularization with QFR-Guided PCI: A Sub-Study from the FAVOR III China Trial

A sub-study from the FAVOR III China trial has shown that QFR-guided PCI results in physiologically appropriate selection of treated lesions and complete revascularization compared with angiography-guided PCI, which may be linked to a higher 1-year event avoidance rate with QFR-guided PCI, according to Dr. Kefei Dou, of Fuwai Hospital in Beijing, during the Hotlines and Late-breaking trials session at EuroPCR 2022.